Succinylcholine, malignant hyperthermia and rhabdomyolysis

The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapi...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2022-06, Vol.194 (25), p.E878-E878
Main Author: Blais, Alex
Format: Article
Language:English
Subjects:
Anesthesiology
Fever
Hyperthermia
Immunization
Letters
Rhabdomyolysis
Severe acute respiratory syndrome coronavirus 2
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapid sequence tracheal intubation outside of the operating room. Here, Blais highlights Salter et al's case study of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination.
ISSN:0820-3946
1488-2329
DOI:10.1503/cmaj.146480-l